Literature DB >> 19433918

Apolipoprotein E receptors in the nervous system.

Joachim Herz1.   

Abstract

PURPOSE OF REVIEW: Over the past few years, apolipoprotein E (ApoE) receptors, also known as LDL receptor-related proteins, have distinguished themselves as functionally diverse signaling receptors with pivotal roles not only in the vascular system but also in the nervous system and during development. RECENT
FINDINGS: The expanding roles of ApoE receptors for cellular signal transduction at the same time transcend and integrate their lipid transport roles into a larger biological and clinical context. ApoE receptors are essential for the development of the nervous system, the regulation of synaptic plasticity, neuroprotection and the innervation of the muscle. They also regulate the metabolism of the amyloid precursor protein on multiple levels, implicating them in the pathogenesis of Alzheimer's disease.
SUMMARY: ApoE, a common ligand for all members of the evolutionarily ancient LDL receptor gene family, is the major genetic modifier of the age of onset of Alzheimer's disease. The underlying molecular mechanisms remain shrouded in mystery, but the numerous critical functions of ApoE receptors within and outside the nervous system that have recently emerged make it likely that these multifunctional signal modulators participate in Alzheimer's disease pathogenesis. This review attempts to summarize the most recent and relevant findings in this area.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19433918      PMCID: PMC2848396          DOI: 10.1097/MOL.0b013e32832d3a10

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  47 in total

1.  Expanding functions of lipoprotein receptors.

Authors:  Joachim Herz; Ying Chen; Irene Masiulis; Li Zhou
Journal:  J Lipid Res       Date:  2008-11-17       Impact factor: 5.922

Review 2.  VPS10P-domain receptors - regulators of neuronal viability and function.

Authors:  Thomas E Willnow; Claus M Petersen; Anders Nykjaer
Journal:  Nat Rev Neurosci       Date:  2008-11-12       Impact factor: 34.870

3.  Crk and Crk-like play essential overlapping roles downstream of disabled-1 in the Reelin pathway.

Authors:  Tae-Ju Park; Tom Curran
Journal:  J Neurosci       Date:  2008-12-10       Impact factor: 6.167

4.  Cerebellar hypoplasia, with quadrupedal locomotion, caused by mutations in the very low-density lipoprotein receptor gene.

Authors:  S Türkmen; K Hoffmann; Osman Demirhan; Defne Aruoba; N Humphrey; S Mundlos
Journal:  Eur J Hum Genet       Date:  2008-03-26       Impact factor: 4.246

5.  Ang II-stimulated migration of vascular smooth muscle cells is dependent on LR11 in mice.

Authors:  Meizi Jiang; Hideaki Bujo; Kenji Ohwaki; Hiroyuki Unoki; Hiroyuki Yamazaki; Tatsuro Kanaki; Manabu Shibasaki; Kazuhiko Azuma; Kenichi Harigaya; Wolfgang J Schneider; Yasushi Saito
Journal:  J Clin Invest       Date:  2008-08       Impact factor: 14.808

6.  Loss of LR11/SORLA enhances early pathology in a mouse model of amyloidosis: evidence for a proximal role in Alzheimer's disease.

Authors:  Sara E Dodson; Olav M Andersen; Vinit Karmali; Jason J Fritz; Dongmei Cheng; Junmin Peng; Allan I Levey; Thomas E Willnow; James J Lah
Journal:  J Neurosci       Date:  2008-11-26       Impact factor: 6.167

7.  Thrombospondin-1 binds to ApoER2 and VLDL receptor and functions in postnatal neuronal migration.

Authors:  Sophia M Blake; Vera Strasser; Nuno Andrade; Sarah Duit; Reinhold Hofbauer; Wolfgang J Schneider; Johannes Nimpf
Journal:  EMBO J       Date:  2008-10-23       Impact factor: 11.598

8.  Identification of a nonsense mutation in the very low-density lipoprotein receptor gene (VLDLR) in an Iranian family with dysequilibrium syndrome.

Authors:  Lia Abbasi Moheb; Andreas Tzschach; Masoud Garshasbi; Kimia Kahrizi; Hossein Darvish; Yaser Heshmati; Alireza Kordi; Hossein Najmabadi; Hans Hilger Ropers; Andreas Walter Kuss
Journal:  Eur J Hum Genet       Date:  2007-11-28       Impact factor: 4.246

9.  An LRP8 variant is associated with familial and premature coronary artery disease and myocardial infarction.

Authors:  Gong-Qing Shen; Lin Li; Domenico Girelli; Sara B Seidelmann; Shaoqi Rao; Chun Fan; Jeong Euy Park; Quansheng Xi; Jing Li; Ying Hu; Oliviero Olivieri; Kandice Marchant; John Barnard; Roberto Corrocher; Robert Elston; June Cassano; Susan Henderson; Stanley L Hazen; Edward F Plow; Eric J Topol; Qing K Wang
Journal:  Am J Hum Genet       Date:  2007-08-31       Impact factor: 11.025

10.  Common genetic variation within the low-density lipoprotein receptor-related protein 6 and late-onset Alzheimer's disease.

Authors:  Giancarlo V De Ferrari; Andreas Papassotiropoulos; Travis Biechele; Fabienne Wavrant De-Vrieze; Miguel E Avila; Michael B Major; Amanda Myers; Katia Sáez; Juan P Henríquez; Alice Zhao; M Axel Wollmer; Roger M Nitsch; Christoph Hock; Chris M Morris; John Hardy; Randall T Moon
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-21       Impact factor: 11.205

View more
  33 in total

1.  PCSK9 is not involved in the degradation of LDL receptors and BACE1 in the adult mouse brain.

Authors:  Mali Liu; Guoxin Wu; Jennifer Baysarowich; Michael Kavana; George H Addona; Kathleen K Bierilo; John S Mudgett; Guillaume Pavlovic; Ayesha Sitlani; John J Renger; Brian K Hubbard; Timothy S Fisher; Celina V Zerbinatti
Journal:  J Lipid Res       Date:  2010-05-07       Impact factor: 5.922

Review 2.  The ins and outs of cholesterol in the vertebrate retina.

Authors:  Steven J Fliesler; Lionel Bretillon
Journal:  J Lipid Res       Date:  2010-09-22       Impact factor: 5.922

3.  Hormonal modulators of glial ABCA1 and apoE levels.

Authors:  Jianjia Fan; Yoko Shimizu; Jeniffer Chan; Anna Wilkinson; Ayaka Ito; Peter Tontonoz; Edie Dullaghan; Liisa A M Galea; Tom Pfeifer; Cheryl L Wellington
Journal:  J Lipid Res       Date:  2013-09-02       Impact factor: 5.922

Review 4.  Sortilin, a novel APOE receptor implicated in Alzheimer disease.

Authors:  Anne-Sophie Carlo
Journal:  Prion       Date:  2013-10-11       Impact factor: 3.931

5.  Suppression of glymphatic fluid transport in a mouse model of Alzheimer's disease.

Authors:  Weiguo Peng; Thiyagarajan M Achariyar; Baoman Li; Yonghong Liao; Humberto Mestre; Emi Hitomi; Sean Regan; Tristan Kasper; Sisi Peng; Fengfei Ding; Helene Benveniste; Maiken Nedergaard; Rashid Deane
Journal:  Neurobiol Dis       Date:  2016-05-24       Impact factor: 5.996

Review 6.  Cholesterol Metabolism in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets.

Authors:  Lijun Dai; Li Zou; Lanxia Meng; Guifen Qiang; Mingmin Yan; Zhentao Zhang
Journal:  Mol Neurobiol       Date:  2021-01-07       Impact factor: 5.590

Review 7.  Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease.

Authors:  David M Holtzman; Joachim Herz; Guojun Bu
Journal:  Cold Spring Harb Perspect Med       Date:  2012-03       Impact factor: 6.915

8.  Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-β.

Authors:  Robert M Koffie; Tadafumi Hashimoto; Hwan-Ching Tai; Kevin R Kay; Alberto Serrano-Pozo; Daniel Joyner; Steven Hou; Katherine J Kopeikina; Matthew P Frosch; Virginia M Lee; David M Holtzman; Bradley T Hyman; Tara L Spires-Jones
Journal:  Brain       Date:  2012-05-26       Impact factor: 13.501

9.  Overexpression of low-density lipoprotein receptor in the brain markedly inhibits amyloid deposition and increases extracellular A beta clearance.

Authors:  Jungsu Kim; Joseph M Castellano; Hong Jiang; Jacob M Basak; Maia Parsadanian; Vi Pham; Stephanie M Mason; Steven M Paul; David M Holtzman
Journal:  Neuron       Date:  2009-12-10       Impact factor: 17.173

Review 10.  Role of cholesterol in APP metabolism and its significance in Alzheimer's disease pathogenesis.

Authors:  M Maulik; D Westaway; J H Jhamandas; S Kar
Journal:  Mol Neurobiol       Date:  2012-09-16       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.